Sanjiv Kaul

Rediff.com » News » Sanjiv Kaul

News for Sanjiv Kaul

News
Business
Movies
Sports

SC rejects review pleas on same-sex marriage verdict

The Supreme Court on Thursday dismissed a batch of pleas seeking to review its October 2023 verdict declining legal sanction to same-sex marriage. IMAGE: A view of the Supreme Court building.......

SC to hear review pleas on same-sex marriage verdict on Jan 9

A five-judge bench of the Supreme Court will on January 9 consider the pleas seeking review of its October 2023 verdict declining legal sanction to same-sex marriage. IMAGE: Students holding......

SC judge opts out of bench to review pleas on same-sex marriage

Senior-most Supreme Court judge Sanjiv Khanna on Wednesday recused himself from considering pleas seeking review of the apex court's judgment last year declining legal recognition to same-sex......

SC to hear pleas to review same-sex marriage verdict on July 10

The Supreme Court is scheduled to consider on July 10 a batch of pleas seeking a review of its last year's judgement which refused to accord legal recognition to same-sex marriage. IMAGE: An LGBT+......

SC dismisses pleas to review Article 370 revocation verdict in Dec 2023

The Supreme Court has dismissed a batch of petitions seeking review of its December 11, 2023 verdict that unanimously upheld the Centre's decision to abrogate provisions of Article 370 bestowing......

PE firms bet big on Indian pharma

Private equity firms are discovering value in picking up small stakes in Indian pharma and healthcare companies. At least two dozen such deals, worth about $400 million (or Rs 1,600 crore), have......

Contract research the new hot-spot

The contract research and manufacturing services may soon replace generic drugs manufacturing as the preferred business option for Indian pharmaceutical industry, if growing revenues from CRAMS......

Big opportunity for Indian pharma companies

Latest figures reveal that generic companies are looking at a bigger opportunity than ever - $73 billion in current annual sales - as patents on 103 blockbuster drugs in the US are slated to lapse......

Merck ploy to outplay generics

US-based pharma multinational Merck's tie-up with two insurance companies to sell its branded simvastatin, Zocor, has helped the innovator company price its branded drug at a level lower than the......

Faster drug passage to India

Since December last year, multinational pharmaceutical companies have launched as many as six patented drugs in India, compared with a dry patch before.With two more drugs and 4-5 vaccines set to......

'So Many Landmark Indian Films Are Crying Out To Be Restored'

'...and showcased in their original beauty.' IMAGE: G Aravindan's classic Thamp. Photograph: Kind courtesy Film Heritage Foundation Shivendra Singh Dungarpur promotes the cause of film restoration......

Nimbus gets marketing rights for DD telecast

The Delhi high court on Wednesday allowed Nimbus to undertake marketing of the India-West Indies cricket series telecast on Doordarshan, while ordering the public broadcaster not to sell the feed......

Key transfers leads to voices of dissent in SAI

A major reshuffle in the Sports Authority of India (SAI) has led to strong voice of dissent among officials with many questioning the wisdom behind transferring key administrators while merging the......

Rediff News